secwatch.observer — SEC 8-K summary
======================================

Issuer:     Core Laboratories Inc. /DE/ (CLB)
CIK:        0001958086
Form:       8-K
Filed at:   2025-01-29T23:59:59+00:00
Accession:  0000950170-25-010552
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Core Lab Q4 revenue $129.2M, EPS $0.15; FY revenue $523.8M up 3%, free cash flow $43.4M up 200%
--------------------------------------------------------------------------------

- Q4 2024 revenue $129.2M (down 4% sequentially, up slightly YoY); GAAP EPS $0.15; ex-items EPS $0.22 (down 12% sequentially, up 16% YoY).
- Q4 operating income ex-items $15.7M (down 14% sequentially, up 4% YoY) with margins of 12%.
- Q4 free cash flow $16.2M (up over 50% sequentially); net debt reduced $11.7M; leverage ratio 1.31.
- FY 2024 revenue $523.8M (up 3%); ex-items operating income $65.3M (up 7%); ex-items EPS $0.87 (up 9%).
- Company repurchased 264,982 shares for $4.9M in Q4; declared $0.01/share dividend payable March 3, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1958086/000095017025010552/0000950170-25-010552-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1958086/000095017025010552/clb-20250129.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-010552

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer